BRIEF-QatarEnergy Increases Participation In Suriname's Offshore Exploration-March 2024-www.financetom.com

BRIEF-QatarEnergy Increases Participation In Suriname's Offshore Exploration

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-QatarEnergy Increases Participation In Suriname's Offshore Exploration

Jul 17, 2024 11:29 PM

July 18 (Reuters) - QATARENERGY:

* QATARENERGY INCREASES PARTICIPATION IN SURINAME'S OFFSHORE

EXPLORATION

* SIGNED AGREEMENT WITH CHEVRON TO ACQUIRE A 20% WORKING

INTEREST

IN A PRODUCTION SHARING CONTRACT FOR BLOCK 5 OFFSHORE SURINAME

* CHEVRON ( CVX ) (THE OPERATOR) WILL RETAIN A 40% INTEREST

* PARADISE OIL COMPANY, AN AFFILIATE OF SURINAME'S NATIONAL

OIL

COMPANY STAATSOLIE WILL OWN REMAINING 40%

Further company coverage:

Previous page： Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals Next page： Update: GSK, Pfizer's RSV Vaccines to Warn of Neurological Disorder Risk, US FDA Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals

Jan 8, 2025

On Tuesday, Avita Medical, Inc. ( RCEL ) revised its revenue guidance for the fourth quarter and full year of 2024. The regenerative medicine company adjusted its projections due to slower-than-expected purchasing by hospital accounts. Avita, which specializes in wound care and skin restoration, anticipates fourth-quarter commercial revenue of approximately $18.4 million. It reflects a 30% year-over-year increase. However, this...

Update: GSK, Pfizer's RSV Vaccines to Warn of Neurological Disorder Risk, US FDA Says

Jan 8, 2025

12:49 PM EST, 01/08/2025 (MT Newswires) -- (Updates with GSK's comments in seventh, eighth and ninth paragraphs.) GSK (GSK) and Pfizer's ( PFE ) respiratory syncytial virus vaccines will carry warnings of increased risk of Guillain-Barre Syndrome, the US Food and Drug Administration said Tuesday on its website. Results from a post-marketing observational study suggested an increased risk of Guillain-Barre...

--Catalyst Pharmaceuticals Reaches Settlement Deal With Teva Over Firdapse Patent Litigation

Jan 8, 2025

12:47 PM EST, 01/08/2025 (MT Newswires) -- Price: 19.20, Change: -0.33, Percent Change: -1.69 ...

Update: Market Chatter: Constellation Energy in Advanced Talks to Buy Calpine in $30 Billion Deal

Jan 8, 2025

12:53 PM EST, 01/08/2025 (MT Newswires) -- (Updates with additional details starting in the third paragraph.) Constellation Energy ( CEG ) is in talks to acquire Calpine in a transaction that would value the energy company at $30 billion, including debt, Bloomberg reported Wednesday. Constellation is in talks with Calpine's private equity owners and a deal could be announced in...